This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2004 Remove Licensing Remove World Health Related Topics
FDA Public Health Compliance Governance COVID-19 Hospitals More Related Topics >
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

DECEMBER 16, 2022

This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells. It also fosters innovation in this crucial biotech sector. The framework contains parallel provisions for donor selection, quality and safety management and oversight.

FDA 40
FDA Compliance COVID-19 Licensing 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

OCTOBER 18, 2023

World Health Organization (WHO) Medical Product Alert N o 5/2023: Substandard (Contaminated) Syrup Medicines, 19 July 2023 Medical Product Alert N o 5/2023 refers to a batch of substandard (contaminated) Naturcold Syrup identified in Cameroon and first reported to WHO on 13 March 2023.

FDA 40
FDA Compliance Licensing World Health 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024